Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,821.77 +3.78 0.13%
FTSE 100 6,729.19 +6.13 0.09%
DAX 8,438.38 +40.38 0.48%
Ticker Volume Price Price Delta
Nikkei 15,360.80 +222.69 1.47%
Hang Seng 23,493.00 +410.35 1.78%
S&P/ASX 200 5,209.04 +28.26 0.55%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

SSRX:US

16.5900 USD 0.0200 0.12%

As of 20:10:00 ET on 05/17/2013.

Company Profile for 3SBio Inc (SSRX)

3SBio, Inc. is a biotechnology company. The Company researches treatments in the areas of nephrology, oncology, supportive cancer care, inflammation, and infectious diseases.

Contact Information

3SBio Inc

No 3 A1, Rd 10 Shenyang
Economy & Tech Devp Zone
Shenyang, 110027
China
Phone: 86-24-2581-1820

Key Executives for 3SBio Inc (SSRX)

Lou JingChairman/CEO/Co-FounderBo TanChief Financial Officer
Dongmei SuVP:R&D/CTOBin HuangVP:Human Resources
Ke LiVP/SecretaryTom FolinsbeeDirector:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil